spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Continuing Sustainability Efforts, Neopac Moves Toward Mono-Material Barrier Tubes Designed for Recyclability

Neopac

Company is in the development stages of food- and pharma-grade tube solutions that align with existing recycling processes.

Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider of high-quality packaging for a broad array of industries and applications, has announced its latest sustainability initiative: developing mono-material barrier tubes that provide exemplary protection for cosmetics, food and pharma products while being compatible with existing recycling processes.

Neopac’s goal is to create tubes that simplify recycling – a crucial aspect of next-level sustainability practices. The EU has announced elevated targets for plastic packaging recyclability, aiming for 50% by 2025 and 55% by 2030. Other geographic areas have introduced similar targets, challenging packaging manufacturers to utilize innovative materials and embrace leaner production and logistics initiatives.

Meeting these targets will require increased cooperation between all actors involved in the life cycles of plastics. Over the long term, modernizing and harmonizing systems for waste management is inevitable; in the nearer term, however, eco-minded advancements in the ways plastics are designed and produced are a must

Multi-layer aluminum-barrier packaging is particularly problematic for recyclers as, among other challenges, it is incompatible with mechanical sorting techniques. Because of this, each year packaging comprised of multi-material plastics causes one million tons of waste in Europe alone. Neopac’s push for mono-material tubes will employ sound packaging science to align with current recycling practices and processes – all while providing its

cosmetics, food and pharma customers with outstanding barrier properties to protect sensitive products.

Slated for market launch later this year, the new portfolio of tubes, called Polyfoil® MMB (mono-material barrier) – will be almost entirely polyethylene (PE) based, containing less that 5% of foreign materials (inks, adhesives, etc.) to avoid disruptions in existing recycling processes. Neopac is aiming to spearhead the application of new, innovative barrier technologies, including highly oriented PE barrier films (MDO), thin film ethylene vinyl alcohol (EVOH) layers, barrier lacquers and ceramic barrier films.

In addition to premium product protection, the Polyfoil® MMB tubes will offer broad options for appealing aesthetics. Notably, the tubes will incorporate metallized tube body options owing to an ultra-thin “sandwich layer” that, in terms of recyclability, is widely accepted. White and transparent versions also will be available. Due to the reduced overall wall thickness, the lightweight tubes will offer as much as 40% tube body weight reduction compared to standard Polyfoil® tubes with aluminum barriers – while keeping very similar haptics.

Neopac also is currently conducting tests to convert caps from PP to PE, which is another goal being explored for the near future.

“The push for enhanced recyclability is undeniable, with nearly 9 in 10 Europeans worried about the impact of plastics on the environment while only 5% of plastic materials are currently being reused,” said Martina Christiansen, Director Sales Tubes Neopac. “Technology must play a role in meeting higher recycling standards, and mono-material barrier tubes will represent a sizable step forward in packaging science.”

Neopac has consistently been at the forefront of the packaging sustainability movement; notably, the company recently released a Tube Design Guide for Recyclability. The company also offers an EcoDesign portfolio, primarily for cosmetics and personal care applications, that includes Recycled Tube featuring 75% recycled, “food-grade light” compliant polyethylene plastics; Sugarcane Tube, made from renewable raw materials and offering the same characteristics and processability as fossil-based polyethylene; and PICEA™ Tube, comprised of 95% renewable material in the tube body and shoulder – including 10% of spruce wood from wood waste in sawmills.

# # #

About Hoffmann Neopac


Hoffmann Neopac is a privately-owned company, headquartered in Thun, Switzerland. The group produces high-quality metal and plastic packaging in six locations: HOFFMANN tins in Thun and CMP tins in Holland; Polyfoil® and plastic tubes with NEOPAC in Switzerland, Hungary and the US; and 3D Neopac in India. Its longstanding customers include internationally active pharmaceutical, cosmetics and consumer goods manufacturers in the European, North American and Asian markets.

ncluding its new production facility in the United States, Neopac employs around 1,250 employees and has a capacity of 1.3 billion tubes. The company is dedicated to sustainability in both its manufacturing processes and corporate culture, including a dedicated eco-conscious packaging portfolio. For more information, visit www.neopac.com.
web www.neopac.com/
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line maintenance treatment of patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the Phase III POLO trial, which were published in The New England Journal of Medicine.
More info >>


White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement